The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Immunology
(Sep 2017)
Commentary: CD6 As a Potential Target for Treating Multiple Sclerosis
Marta Consuegra-Fernández,
Marcos Isamat,
Francisco Lozano,
Francisco Lozano,
Francisco Lozano
Affiliations
Marta Consuegra-Fernández
Immunoreceptors of the Innate and Adaptive System, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Marcos Isamat
Immunoreceptors of the Innate and Adaptive System, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Francisco Lozano
Immunoreceptors of the Innate and Adaptive System, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Francisco Lozano
Servei d’Immunologia, Centre de Diagnòstic Biomèdic, Hospital Clínic de Barcelona, Barcelona, Spain
Francisco Lozano
Departament de Biomedicina, Universitat de Barcelona, Barcelona, Spain
DOI
https://doi.org/10.3389/fimmu.2017.01217
Journal volume & issue
Vol. 8
Abstract
Read online
No abstracts available.
Keywords
CD6
multiple sclerosis
itolizumab
UMCD6
experimental autoimmune encephalomyelitis
collagen-induced arthritis
WeChat QR code
Close